NanJing Pharmaceutical Company Limited reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 37,436.17 million compared to CNY 33,396.83 million a year ago. Revenue was CNY 37,436.17 million compared to CNY 33,396.83 million a year ago.

Net income was CNY 470.24 million compared to CNY 346.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.38 compared to CNY 0.33 a year ago. Diluted earnings per share from continuing operations was CNY 0.38 compared to CNY 0.33 a year ago.